WELLESLEY, MA--(Marketwired - December 08, 2015) - Allurion Technologies announced today that its Elipse™ Gastric Balloon has received a CE mark allowing sale of the product in the European Union.

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced new clinical data on the ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, today announced the Premarket Approval (PMA) ...

New research shows Allurion Technologies’ Elipse balloon is a safe and effective procedureless weight-loss treatment, according to Science Daily. Researchers presented the data at the European Obesity ...

Allurion Technologies is hoping to be able to get FDA approval to launch its obesity treatment balloon in 2020. The Natick, MA-based company said it was making progress toward its goal of getting ...

Allurion Technologies’ Elipse Gastric Balloon has received a CE Mark allowing sale of the product in the European Union, according to a Med Device Online report. 1. Elipse is the world’s first ...

Allurion, a Boston-based startup offering a non-invasive gastric balloon by swallowing a pill, has gained $27 million in Series C funding from previous investor Romulus Capital, with new participation ...

A Natick weight loss device company has begun a clinical trial in the U.S. with the hopes of soon gaining U.S. Food and Drug Administration approval. Allurion Technologies, makers of a gastric balloon ...

Allurion Technologies repayed a $1.1M state loan earlier this year. Pictured in the center are the company's new CEO Shantanu Gaur (left) and former CEO Jonathan Wecker. Natick biotech Allurion ...

WELLESLEY, MA--(Marketwired - December 08, 2015) - Allurion Technologies announced today that its Elipse™ Gastric Balloon has received a CE mark allowing sale of the product in the European Union.